Secondary Logo

Journal Logo

November/December 2014 - Volume 37 - Issue 9
pp: 427-468

Adjuvant Low-Dose Interleukin-2 (IL-2) Plus Interferon-α (IFN-α) in Operable Renal Cell Carcinoma (RCC): A Phase III, Randomized, Multicentre Trial of the Italian Oncology Group for Clinical Research (GOIRC)

Passalacqua, Rodolfo; Caminiti, Caterina; Buti, Sebastiano; More

Journal of Immunotherapy. 37(9):440-447, November/December 2014.

Activation and Propagation of Tumor-infiltrating Lymphocytes on Clinical-grade Designer Artificial Antigen-presenting Cells for Adoptive Immunotherapy of Melanoma

Forget, Marie-Andrée; Malu, Shruti; Liu, Hui; More

Journal of Immunotherapy. 37(9):448-460, November/December 2014.